Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients

被引:38
|
作者
Torisu-Itakura, Hitoe [1 ]
Lee, Jonathan H. [1 ,3 ]
Huynh, Young [1 ]
Ye, Xing [1 ,2 ]
Essner, Richard [1 ,3 ]
Morton, Donald L. [3 ]
机构
[1] John Wayne Canc Inst, St Johns Hlth Ctr, Dept Mol Therapeut, Santa Monica, CA USA
[2] John Wayne Canc Inst, St Johns Hlth Ctr, Dept Biostat, Santa Monica, CA USA
[3] John Wayne Canc Inst, St Johns Hlth Ctr, Div Surg Oncol, Santa Monica, CA USA
关键词
monocyte; melanoma; allogeneic whole-cell vaccine; interleukin-10;
D O I
10.1097/CJI.0b013e318158795b
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are no standard methods to predict response to treatment or outcome of stage IV melanoma. Our previous assessment of peripheral blood mononuclear cells (PBMC) from immunized patients demonstrated that interleukin (IL)-10 expression might be associated with prognosis. However, PBMC are a mixture of CD4(+) cells, CD8(+) cells, and monocytes. This study identified the subset of PBMC responsible for IL-10 expression and evaluated the prognostic value of IL-10 expression in immunized stage IV patients. Eighty-seven patients with stage IV melanoma were randomly selected from our database. All patients had received an allogeneic melanoma whole-cell vaccine (Canvaxin) after complete resection of clinical disease. Blood samples had been collected serially during Canvaxin administration and cryopreserved. Intracellular IL-10 expression was assessed by double staining fluorescence-activated cell sorter. CD14(+) monocytes are the predominant PBMC producing IL-10. Sixteen weeks after treatment (week 16), IL-10 levels were significantly (P = 0.02) higher in poor-survival patients than those with favorable outcomes. Patients were separated into 2 groups on the basis of the CD14+ monocyte IL-10 response: either increasing or decreasing IL-10 expression from preimmunization (week 0) to week 16 blood draws. Patients with increasing IL-10 levels had significantly shorter survival than those whose IL-10 levels decreased at week 16 (P < 0.0001). Multivariate analysis demonstrated that trends in IL-10 levels inversely correlated with survival (P < 0.0001). We conclude that CDl4(+) monocytes are the dominant cellular source of IL-10 among PBMC and that changes in IL-10 expression may serve as an immunologic-based surrogate for predicting outcome for stage IV patients after surgical resection.
引用
收藏
页码:831 / 838
页数:8
相关论文
共 50 条
  • [21] Morphine Reciprocally Regulates IL-10 and IL-12 Production by Monocyte-Derived Human Dendritic Cells and Enhances T Cell Activation
    Davorka Messmer
    Ikusuke Hatsukari
    Naoko Hitosugi
    Ingo G H Schmidt-Wolf
    Pravin C Singhal
    Molecular Medicine, 2006, 12 : 284 - 290
  • [22] Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response
    Liu, GT
    Ng, H
    Akasaki, Y
    Yuan, XP
    Ehtesham, M
    Yin, D
    Black, KL
    Yu, JS
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (06) : 1680 - 1687
  • [23] Expression profile in monocyte-derived macrophages activated with IL-1 and IL-6
    Wegrzyn, P
    Jura, J
    Guzik, K
    Jarzab, B
    Oczko, M
    Wiench, M
    Koj, A
    TISSUE ANTIGENS, 2004, 64 (04): : 397 - 397
  • [24] The effects of zoledronate on monocyte-derived dendritic cells from melanoma patients differ depending on the clinical stage of the disease
    Failli, Alessandra
    Legitimo, Annalisa
    Orsini, Giulia
    Romanini, Antonella
    Consolini, Rita
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3375 - 3382
  • [25] Regulation of IL-10 secretion and mRNA expression by 1,25-dihydroxyvitamin D5 and its analogue tacalcitol in monocyte-derived dendritic cells
    Zhu, K
    Mrowietz, U
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 474 - 474
  • [26] IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
    Narmeen Ahmad
    Aula Ammar
    Sarah J. Storr
    Andrew R. Green
    Emad Rakha
    Ian O. Ellis
    Stewart G. Martin
    Cancer Immunology, Immunotherapy, 2018, 67 : 537 - 549
  • [27] IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
    Ahmad, Narmeen
    Ammar, Aula
    Storr, Sarah J.
    Green, Andrew R.
    Rakha, Emad
    Ellis, Ian O.
    Martin, Stewart G.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (04) : 537 - 549
  • [28] Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10
    Wilkin, F
    Stordeur, P
    Goldman, M
    Boeynaems, JM
    Robaye, B
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (09) : 2409 - 2417
  • [29] Monocyte-derived IL-10-secreting dendritic cells in choroid plexus epithelium
    Serot, JM
    Béné, MC
    Foliguet, B
    Faure, GC
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 105 (02) : 115 - 119
  • [30] Expression of IL-10 in patients with ovarian carcinoma
    Mustea, A
    Könsgen, D
    Braicu, EI
    Pirvulescu, C
    Sun, PM
    Sofroni, D
    Lichtenegger, W
    Sehouli, J
    ANTICANCER RESEARCH, 2006, 26 (2C) : 1715 - 1718